1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Jung, S.
Michalek, M.
Shomali, M.
Soennichsen, F.D.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
US
Biochem.Biophys.Res.Commun.
BBRCA9
0146
0006-291X
459
668
672
10.1016/j.bbrc.2015.02.168
25769951
Solution structure and functional studies of the highly potent equine antimicrobial peptide DEFA1.
2015
10.2210/pdb2mxq/pdb
pdb_00002mxq
4086.807
Paneth cell-specific alpha-defensin 1
residues 65-98
1
syn
polymer
no
no
SCTCRRAWICRWGERHSGKCIDQKGSTYRLCCRR
SCTCRRAWICRWGERHSGKCIDQKGSTYRLCCRR
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
database_2
pdbx_database_status
repository
Initial release
Database references
Other
1
0
2015-04-22
1
1
2023-06-14
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.status_code_nmr_data
BMRB
Y
RCSB
2015-01-12
REL
REL
REL
REL
9796
domestic horse,equine
Equus caballus
sample
structures with the lowest energy
100
10
2D 1H-1H NOESY
2D 1H-1H TOCSY
0.5
mM
0.02
5.7
ambient
298
K
torsion angle dynamics
1
lowest energy
0.5 mM protein, 93% H2O/7% D2O
93% H2O/7% D2O
Guntert P.
refinement
CYANA
600
Bruker
AMX
Bruker AMX
SER
1
n
1
SER
1
A
CYS
2
n
2
CYS
2
A
THR
3
n
3
THR
3
A
CYS
4
n
4
CYS
4
A
ARG
5
n
5
ARG
5
A
ARG
6
n
6
ARG
6
A
ALA
7
n
7
ALA
7
A
TRP
8
n
8
TRP
8
A
ILE
9
n
9
ILE
9
A
CYS
10
n
10
CYS
10
A
ARG
11
n
11
ARG
11
A
TRP
12
n
12
TRP
12
A
GLY
13
n
13
GLY
13
A
GLU
14
n
14
GLU
14
A
ARG
15
n
15
ARG
15
A
HIS
16
n
16
HIS
16
A
SER
17
n
17
SER
17
A
GLY
18
n
18
GLY
18
A
LYS
19
n
19
LYS
19
A
CYS
20
n
20
CYS
20
A
ILE
21
n
21
ILE
21
A
ASP
22
n
22
ASP
22
A
GLN
23
n
23
GLN
23
A
LYS
24
n
24
LYS
24
A
GLY
25
n
25
GLY
25
A
SER
26
n
26
SER
26
A
THR
27
n
27
THR
27
A
TYR
28
n
28
TYR
28
A
ARG
29
n
29
ARG
29
A
LEU
30
n
30
LEU
30
A
CYS
31
n
31
CYS
31
A
CYS
32
n
32
CYS
32
A
ARG
33
n
33
ARG
33
A
ARG
34
n
34
ARG
34
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
THR
3
-160.96
82.83
1
A
CYS
4
-58.75
97.66
1
A
CYS
10
-129.34
-169.77
1
A
ARG
11
-57.31
-74.78
1
A
TRP
12
-167.17
115.58
1
A
SER
17
-158.34
23.68
1
A
ILE
21
-115.10
71.89
1
A
ASP
22
-146.08
-42.52
1
A
LYS
24
62.03
102.09
1
A
THR
27
-175.62
-47.45
1
A
LEU
30
-59.99
-170.86
2
A
THR
3
-161.66
84.26
2
A
CYS
4
-68.00
87.26
2
A
ALA
7
-178.56
143.48
2
A
ARG
11
-54.94
-77.85
2
A
TRP
12
179.66
124.76
2
A
SER
17
-168.39
85.87
2
A
GLN
23
-58.72
-76.62
2
A
LYS
24
178.62
-74.92
2
A
THR
27
-150.81
-71.93
3
A
ARG
11
-51.12
-75.50
3
A
TRP
12
-172.90
131.29
3
A
CYS
20
54.51
-176.52
3
A
ILE
21
-153.23
76.16
3
A
ASP
22
-170.76
-74.95
3
A
GLN
23
-68.31
-170.35
3
A
SER
26
-52.04
-76.32
3
A
LEU
30
-57.53
-174.53
4
A
CYS
2
-141.23
16.99
4
A
THR
3
-162.01
81.96
4
A
CYS
4
-50.38
104.12
4
A
ARG
6
-113.33
-167.48
4
A
ALA
7
66.07
174.82
4
A
ARG
11
-50.49
-76.64
4
A
TRP
12
-178.28
126.99
4
A
SER
17
-166.69
74.48
4
A
ILE
21
51.50
88.58
4
A
ASP
22
-158.94
-74.79
4
A
LYS
24
-61.33
-169.25
4
A
SER
26
-64.93
-75.01
4
A
TYR
28
65.37
116.10
5
A
CYS
4
-87.54
48.41
5
A
ARG
11
-49.41
-75.57
5
A
TRP
12
-179.56
134.63
5
A
ASP
22
-169.45
-49.07
5
A
LYS
24
64.51
110.83
5
A
SER
26
-83.91
-75.72
5
A
LEU
30
-55.56
-179.77
6
A
THR
3
-160.18
90.97
6
A
CYS
10
-110.48
-168.66
6
A
GLU
14
-49.11
166.71
6
A
SER
17
-158.54
48.39
6
A
LYS
19
-66.70
-176.28
6
A
ILE
21
-90.37
49.09
6
A
LYS
24
-179.30
-38.88
6
A
THR
27
-157.37
38.73
6
A
LEU
30
-66.83
-177.19
7
A
THR
3
-161.17
74.04
7
A
CYS
4
-55.97
98.87
7
A
ALA
7
-178.40
148.07
7
A
ARG
11
-53.08
-77.91
7
A
TRP
12
179.45
124.77
7
A
SER
17
-164.46
81.41
7
A
GLN
23
50.76
-169.06
7
A
LYS
24
-135.35
-75.24
8
A
ARG
11
-50.00
-75.84
8
A
TRP
12
-179.72
133.65
8
A
ASP
22
-51.77
-74.78
8
A
LYS
24
-174.73
-176.28
8
A
SER
26
-126.38
-74.76
8
A
LEU
30
-74.85
-169.33
9
A
CYS
2
-141.18
-69.59
9
A
CYS
4
-65.90
99.12
9
A
ARG
11
-50.69
-75.05
9
A
SER
17
-153.48
52.76
9
A
ASP
22
-58.25
-178.37
9
A
GLN
23
47.34
85.30
9
A
LYS
24
-54.62
99.68
9
A
THR
27
-161.73
27.63
9
A
LEU
30
-53.29
174.33
10
A
CYS
2
-141.85
-60.92
10
A
THR
3
-65.58
90.77
10
A
CYS
4
-67.28
88.06
10
A
ARG
11
-51.11
-75.12
10
A
TRP
12
-174.06
134.10
10
A
HIS
16
59.10
102.96
10
A
SER
17
-175.85
53.58
10
A
LYS
24
63.39
63.66
10
A
SER
26
-92.10
-75.19
10
A
THR
27
-160.53
38.57
10
A
TYR
28
-57.58
-175.31
10
A
LEU
30
69.81
162.36
lowest energy, model1
The solution structure of DEFA1, a highly potent antimicrobial peptide from the horse
1
N
N
disulf
2.104
A
CYS
2
A
SG
CYS
2
1_555
A
CYS
32
A
SG
CYS
32
1_555
disulf
1.915
A
CYS
4
A
SG
CYS
4
1_555
A
CYS
20
A
SG
CYS
20
1_555
disulf
2.032
A
CYS
10
A
SG
CYS
10
1_555
A
CYS
31
A
SG
CYS
31
1_555
ANTIMICROBIAL PROTEIN
ANTIMICROBIAL PROTEIN
A6YB85_HORSE
UNP
1
65
A6YB85
SCTCRRAWICRWGERHSGKCIDQKGSTYRLCCRR
65
98
2MXQ
1
34
A6YB85
A
1
1
34